| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 147.42B | 143.74B | 148.48B | 142.79B | 138.06B | 128.60B |
| Gross Profit | 50.61B | 51.23B | 50.57B | 50.46B | 51.93B | 50.81B |
| EBITDA | 11.87B | 14.65B | 12.40B | 15.55B | 15.10B | 17.41B |
| Net Income | 1.74B | 2.48B | 2.71B | 8.07B | 9.04B | 10.15B |
Balance Sheet | ||||||
| Total Assets | 169.71B | 168.26B | 177.46B | 175.69B | 169.34B | 161.84B |
| Cash, Cash Equivalents and Short-Term Investments | 21.49B | 24.70B | 26.48B | 26.70B | 32.74B | 44.21B |
| Total Debt | 16.14B | 15.91B | 16.18B | 15.15B | 15.48B | 15.50B |
| Total Liabilities | 50.15B | 47.13B | 53.29B | 49.38B | 49.71B | 50.66B |
| Stockholders Equity | 120.11B | 121.66B | 124.69B | 126.69B | 119.88B | 111.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.26B | 6.06B | 1.03B | -4.54B | 7.53B |
| Operating Cash Flow | 0.00 | 8.21B | 10.41B | 6.92B | 5.54B | 14.99B |
| Investing Cash Flow | 0.00 | -3.78B | -3.04B | -6.04B | -12.62B | -7.78B |
| Financing Cash Flow | 0.00 | -6.64B | -8.01B | -7.12B | -4.89B | -3.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥42.46B | 8.17 | ― | 3.74% | 4.73% | 17.57% | |
71 Outperform | ¥31.93B | 8.57 | ― | 3.59% | 6.27% | 28.43% | |
68 Neutral | ¥123.53B | 10.61 | 12.89% | 3.40% | 3.44% | -3.09% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥57.18B | 14.86 | ― | 1.49% | 8.57% | 11.82% | |
55 Neutral | ¥98.42B | 43.49 | ― | 3.53% | -3.19% | -4.14% | |
55 Neutral | ¥466.47B | -31.80 | 1.44% | 4.80% | 0.40% | 306.91% |